Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions.
Schavgoulidze A, Perrot A, Cazaubiel T, Leleu X, Montes L, Jacquet C, Belhadj K, Brechignac S, Frenzel L, Chalopin T, Rey P, Schiano de Collela JM, Dib M, Caillot D, Macro M, Fontan J, Buisson L, Pavageau L, Roussel M, Manier S, Mohty M, Martinet L, Avet-Loiseau H, Corre J. Schavgoulidze A, et al. Among authors: belhadj k. Blood Cancer J. 2023 Oct 26;13(1):160. doi: 10.1038/s41408-023-00933-4. Blood Cancer J. 2023. PMID: 37880285 Free PMC article. No abstract available.
[Intrasinusal bone marrow lymphoid infiltration].
Badoual C, Plonquet A, Belhadj K, Imbert M, Gaulard P. Badoual C, et al. Among authors: belhadj k. Ann Pathol. 2002 Sep;22(4):337-8. Ann Pathol. 2002. PMID: 12410162 French. No abstract available.
Gammadelta T-cell lymphomas.
Gaulard P, Belhadj K, Reyes F. Gaulard P, et al. Among authors: belhadj k. Semin Hematol. 2003 Jul;40(3):233-43. doi: 10.1016/s0037-1963(03)00137-9. Semin Hematol. 2003. PMID: 12876672 Review.
Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.
Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R, Deconinck E, Charlotte F, Leblond V, Labouyrie E, Lederlin P, Emile JF, Delmas-Marsalet B, Arnulf B, Zafrani ES, Gaulard P. Belhadj K, et al. Blood. 2003 Dec 15;102(13):4261-9. doi: 10.1182/blood-2003-05-1675. Epub 2003 Aug 7. Blood. 2003. PMID: 12907441 Free article. Review.
Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
Coiffier B, Mounier N, Bologna S, Fermé C, Tilly H, Sonet A, Christian B, Casasnovas O, Jourdan E, Belhadj K, Herbrecht R; Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma. Coiffier B, et al. Among authors: belhadj k. J Clin Oncol. 2003 Dec 1;21(23):4402-6. doi: 10.1200/JCO.2003.04.115. Epub 2003 Oct 27. J Clin Oncol. 2003. PMID: 14581437 Clinical Trial.
118 results